Abstract: In some embodiments, an electronic device presents media items from different media applications in a unified media browsing application. In some embodiments, an electronic device facilitates browsing of media from different media applications based on category of media (e.g., movies, television shows, etc.). In some embodiments, an electronic device facilitates setup of a unified media browsing application that presents media items from different media applications in a unified media browsing user interface. In some embodiments, an electronic device displays multiple episodes of a collection of episodic content (e.g., a television series) in a user interface for the collection of episodic content. In some embodiments, an electronic device displays representations of, and provides access to, live-event media items accessible on the electronic device.

Abstract: An electronic device provides, to a display, data to present a user interface that includes a plurality of user interface objects, and a current focus on a first user interface object. While the display is presenting the user interface, the electronic device receives an input that corresponds to a movement of a contact across on a touch-sensitive surface. The electronic device, in response to receiving the input and in accordance with a determination that a first axis is a dominant axis, moves the current focus along the first axis by a first amount and along the second axis by a second amount. The amount of movement of the current focus along the second axis is reduced to a first non-zero amount by a scaling factor that is based on one or more inputs received prior to receiving the input.

Abstract: A pharmaceutical composition is provided which is in the form of a plurality of beadlets, adapted to be filled into pharmaceutical hard shell capsules, or compressed into tablets, which beadlets are formed of a pharmaceutical such as an ACE inhibitor, for example, captopril, a beta-blocker such as nadolol, propranolol or atenolol, a calcium channel blocker such as diltiazem or nifedipine or other pharmaceuticals including combinations thereof, binder such as microcrystalline cellulose, and at least 5% by weight of an acid processing aid, such as citric acid, which imparts plasticity to the wet mass needed for efficient extrusion and spheronization. A method for forming beadlets is also provided which includes the steps of extruding a composition as described above, and subjecting the resulting extrudate to a spheronization step wherein an acid processing aid such as citric acid is employed to improve processing and form improved beadlets.